PAM
CMPX icon

Panagora Asset Management’s Compass Therapeutics CMPX Stock Holding History

Panagora Asset Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,840
Closed -$41.2K – 1171
2025
Q2 		$41.2K Sell
15,840
-154,767
-91% -$319K ﹤0.01% 1106
2025
Q1 		$324K Sell
170,607
-859
-0.5% -$2.28K ﹤0.01% 917
2024
Q4 		$249K Buy
171,466
+29,855
+21% +$49.6K ﹤0.01% 1009
2024
Q3 		$261K Buy
141,611
+73,343
+107% +$91.4K ﹤0.01% 1078
2024
Q2 		$68.3K Buy
+68,268
New +$99.7K ﹤0.01% 1169

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return